Facebook Pixel image Hisyaryumon BT15-063 | Digimon digimon Cards

digimon > Cards > Hisyaryumon BT15-063

Hisyaryumon BT15-063 image
set min mtgo
- 0.00 0.0 tix
Icons of mtg
Name Hisyaryumon BT15-063 Edit card
Type Digimon - ultimate vaccine beast dragon/x antibody/digipolice
Description Effect [Digivolve] Lv.4 w/[X Antibody]/[DigiPolice] trait: Cost 3<Blocker>[All Turns] When an effect suspends another Digimon or Tamer, if a Tamer card with the [DigiPolice] trait is in this Digimon's digivolution cards, this Digimon may digivolve inSee more
Artist Digimon Card Game
Set Digimon card game exceed apocalypse [bt15] #BT15-063
Wallpaper Hisyaryumon BT15-063 Crop image Wallpaper download
Image Hisyaryumon BT15-063 Full hd image download
⚠️

Tierlist

No Rank

Grade it yourself

Meta types

Edit card

Legality between formats

Edit card

Table of contents

About Hisyaryumon BT15-063

Hisyaryumon BT15-063, Digimon - ultimate vaccine beast dragon/x antibody/digipolice, designed by Digimon Card Game first released in May, 2024 in the set Exceed Apocalypse.

This Hisyaryumon BT15-063 card would be beneficial in a deck focused on Digimon with the [Beast Dragon] or [DigiPolice] trait, as it offers a unique ability to digivolve without paying the cost under specific conditions, providing a strategic advantage. It could work well in a control-oriented deck that aims to disrupt the opponent's strategy by utilizing the [Blocker] ability and the ability to unsuspend Digimon with the specified traits. However, depending on the specific strategy of the deck, there may be better cards available that offer more consistent or powerful effects, so it's worth considering the overall synergy and effectiveness of the card in the context of the deck's goals before including it.

Where to buy

Seller image Ebay.com

Visit store
Seller image Printing proxies

$ 0.75 Visit store

*This site contains affiliate links for which we may be compensated

Group by

Price alert ?

Alert me when price gets to

Price trend history

loading
Profile imageSign in and join the conversation

— Comments0

User profile image

Be the first to comment